Delirium: Where do we stand?

被引:6
|
作者
Pae C.-U. [1 ,2 ]
Marks D.M.
Han C.
Patkar A.A.
Masand P.
机构
[1] Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul 137701, 505 Banpo-Don, Seocho-Gu
[2] Department of Psychiatry and Behavioral Medicine, Duke University Medical Center, Durham, NC 27705
关键词
Haloperidol; Risperidone; Olanzapine; Quetiapine; Aripiprazole;
D O I
10.1007/s11920-008-0040-3
中图分类号
学科分类号
摘要
Clinicians are likely to encounter delirium frequently, particularly in inpatient and intensive care settings. However, delirium is underrecognized and undertreated because of its heterogeneous and fluctuating presentation and due to the limitations in resources and training in contemporary clinical settings. Translation of current knowledge about delirium into clinical practice may improve patient care and benefit public health economics. Hence, this review comprehensively discusses the phenomenology and pathophysiology of delirium and its presenting features, risk factors, differential diagnoses, assessment, prognosis, and treatment with antipsychotics; the goal is to facilitate better prevention, recognition, and treatment of delirium. Available research is reviewed, limitations of the research are discussed, and future directions for further delirium research are identified. Copyright © 2008 by Current Medicine Group LLC.
引用
收藏
页码:240 / 248
页数:8
相关论文
共 50 条
  • [1] Risperidone for delirium: where do we stand?
    Bocatto, Mayra Q.
    Shiozawa, Pedro
    Trevizol, Alisson Paulino
    Cordeiro, Quirino
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (05) : 306 - 306
  • [2] Where do we stand?
    Thompson, ID
    [J]. FORESTRY CHRONICLE, 2003, 79 (03): : 381 - 382
  • [3] Where do we stand?
    不详
    [J]. INTERNATIONAL JOURNAL OF PRODUCTIVITY AND PERFORMANCE MANAGEMENT, 2010, 59 (03) : 79 - 86
  • [4] Where do we stand?
    Catt, Graham
    [J]. AUSTRALIAN VETERINARY JOURNAL, 2008, 86 (07) : N8 - N8
  • [5] WHERE DO WE STAND
    MCMILLAN, B
    [J]. IRE TRANSACTIONS ON INFORMATION THEORY, 1957, 3 (03): : 173 - 174
  • [6] WHERE DO WE STAND?
    Stolper, Gustav
    [J]. HARVARD BUSINESS REVIEW, 1931, 9 (03) : 289 - 298
  • [7] WHERE DO WE STAND
    不详
    [J]. MILITARY MEDICINE, 1961, 126 (01) : 66 - &
  • [8] Gephyrin: where do we stand, where do we go?
    Fritschy, Jean-Marc
    Harvey, Robert J.
    Schwarz, Guenter
    [J]. TRENDS IN NEUROSCIENCES, 2008, 31 (05) : 257 - 264
  • [9] Epilepsy: Where do we stand? Where are we headed?
    Elger, C. E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 8 - 8
  • [10] ColVI myopathies: where do we stand, where do we go?
    Valérie Allamand
    Laura Briñas
    Pascale Richard
    Tanya Stojkovic
    Susana Quijano-Roy
    Gisèle Bonne
    [J]. Skeletal Muscle, 1